Exploring how different precursors like nicotinamide and NR impact enzymes like sirtuins and PARPS, and discussing the benefits of NR for stressed cells in conditions of metabolic stress.
Charles Brenner, PhD is the chair of the new Department of Diabetes & Cancer Metabolism at the Beckman Research Institute of the City of Hope National Medical Center. He is a major contributor to work on nicotinamide adenine dinucleotide metabolism, who discovered the eukaryotic nicotinamide riboside (NR) kinase pathway.